Subject    :    Diabetes & Metabolism Journal - Volume 40(3); June 2016
Writer jiyeon
Date 2016-07-12 15:23:25 Hit 1,953
 
Diabetes & Metabolism Journal (DMJ) - Open Access
 
Table of Contents Alert
Volume 40(3); June 2016
Featured Articles
Feasibility of a Patient-Centered, Smartphone-Based Diabetes Care System: A Pilot Study. Diabetes Metab J. 2016;40(3):192-201.
 
Mobile healthcare systems are rapidly evolving, and numerous applications have been developed for patients with chronic diseases requiring daily monitoring and management. However, most of them are not comprehensive nor patient-centered. We developed a patient-centered, smartphone-based diabetes care system (PSDCS). This is a 12-week study aiming to test the feasibility of HbA1c reduction with the PSDCS. HbA1c and fasting plasma glucose levels decreased significantly from baseline. The components of diabetes self-care activities were significantly improved. There were no severe adverse events during the intervention. Further studies are necessary to confirm its therapeutic efficacy.
 
Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes. Diabetes Metab J. 2016;40(3):202-210.
 
Because intensive glycemic control has beneficial effects on vascular complications, incidence of severe hypoglycemia (SH) has increased according to the implementation of intensive glycemic control. Which has shown beneficial effects on vascular complications in patients with type 2 diabetes. We conducted a prospective cohort study from 2000 to 2010 to evaluate the association between SH and risk of all-cause mortality and cardiovascular mortality. The experience of SH was significantly associated with an increased risk of all-cause mortality (hazard ratio [HR] 2.64; 95% confidence interval [CI] 1.39-5.02; P = 0.003) and cardiovascular mortality (HR 6.34; 95% CI 2.02-19.87; P = 0.002) after adjusting for various confounding factors.
 
Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice. Diabetes Metab J. 2016;40(3):211-221.
 
Dipeptidyl peptidase-4 (DPP-4) inhibitor has been proven to have a protective effect on diabetic kidney disease (DKD) in patient with type 2 diabetes, but its renoprotective role in type 1 diabetes is less understood. This study was aimed to determine whether gemigliptin has renoprotective effects in streptozotocin (STZ)-induced type 1 diabetic mice. Regardless of its glucose-lowering effect, gemigliptin reduced albuminuria and glomerular basement membrane thickening, and attenuated renal fibrosis in STZ mice. In cultured renal cells, gemigliptin inhibited TGF-β-stimulated type I collagen and fibronectin expression and Smad3 phosphorylation. These results suggest gemigliptin could be used to prevent DKD also in patients with type 1 diabetes.
Reviews
Epidemiology
175
Are We in the Same Risk of Diabetes Mellitus? Gender- and Age-Specific Epidemiology of Diabetes in 2001 to 2014 in the Korean Population
Koo BK, Moon MK.
Diabetes Metab J. 2016 Jun;40(3):175-181.
Sulwon Lecture 2015
Clinical Care/Education
182
Sarcopenia, Frailty, and Diabetes in Older Adults
Jang HC.
Diabetes Metab J. 2016 Jun;40(3):182-189.
Editorial
Complications
190
Hypoglycemia: Culprit or Bystander?
Hwang YC.
Diabetes Metab J. 2016 Jun;40(3):190-191.
Original Articles
Clinical Care/Education
192
Feasibility of a Patient-Centered, Smartphone-Based, Diabetes Care System: A Pilot Study
Kim EK, Kwak SH, Baek S, Lee SL, Jang HC, Park KS, Cho YM.
Diabetes Metab J. 2016 Jun;40(3):192-201.
Complications
202
Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
Cha SA, Yun JS, Lim TS, Hwang S, Yim EJ, Song KH, Yoo KD, Park YM, Ahn YB, Ko SH.
Diabetes Metab J. 2016 Jun;40(3):202-210.
211
Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice
Jung GS, Jeon JH, Choe MS, Kim SW, Lee IK, Kim MK, Park KG.
Diabetes Metab J. 2016 Jun;40(3):211-221.
Genetics
222
APO A2 -265T/C Polymorphism Is Associated with Increased Inflammatory Responses in Patients with Type 2 Diabetes Mellitus
Koohdani F, Sadrzadeh-Yeganeh H, Djalali M, Eshraghian M, Zamani E, Sotoudeh G, Mansournia MA, Keramat L.
Diabetes Metab J. 2016 Jun;40(3):222-229.
Others
230
Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
Kim JH, Kim SS, Baek HS, Lee IK, Chung DJ, Sohn HS, Bae HY, Kim MK, Park JH, Choi YS, Kim YI, Hahm JR, Lee CW, Jo SR, Park MK, Lee KJ, Kim IJ.
Diabetes Metab J. 2016 Jun;40(3):230-239.
240
Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus
Park S, Park SY, Kim YJ, Hong SM, Chon S, Oh S, Woo JT, Kim SW, Kim YS, Rhee SY.
Diabetes Metab J. 2016 Jun;40(3):240-247.
Letter
248
Letter: Hyperglycemia Is Associated with Impaired Muscle Quality in Older Men with Diabetes: The Korean Longitudinal Study on Health and Aging (Diabetes Metab J 2016;40:140-6)
Moon JS.
Diabetes Metab J. 2016 Jun;40(3):248-249.
Response
250
Response: Hyperglycemia Is Associated with Impaired Muscle Quality in Older Men with Diabetes: The Korean Longitudinal Study on Health and Aging (Diabetes Metab J 2016;40:140-6)
Yoon JW, Jang HC.
Diabetes Metab J. 2016 Jun;40(3):250-251.
 
Open Access
DMJ is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. It is indexed in PubMed, PubMed Central, SCOPUS, EMBASE, EBSCO, DOI/CrossRef, Google Scholar, KoreaMed, KoMCI, and KoreaMed Synapse.

Manuscript Submission
Manuscripts should be submitted via an online manuscript-submission system of the Korean Diabetes Association (http://e-dmj.org, or http://submit.e-dmj.org).


             

DMJ Newsletters
No. Subject Date Hit ↑
Notice : Diabetes & Metabolism Journal - Volume 42(2); April 2018 Diabetes & Metabolism Journal - Volume 42(2); April 2018 2018-05-29 313
Notice : Diabetes & Metabolism Journal - Volume 42(1); February 2018 Diabetes & Metabolism Journal - Volume 42(1); February 2018 2018-05-29 305
Notice : Diabetes & Metabolism Journal - Volume 41(6); December 2017 Diabetes & Metabolism Journal - Volume 41(6); December 2017 2018-05-29 312
Notice : Diabetes & Metabolism Journal - Volume 41(5); October 2017 Diabetes & Metabolism Journal - Volume 41(5); October 2017 2018-05-29 314
Notice : Diabetes & Metabolism Journal - Volume 41(4); August 2017 Diabetes & Metabolism Journal - Volume 41(4); August 2017 2018-05-29 443
7 Diabetes & Metabolism Journal - Volume 39(2); April 2015 2015-05-21 2,048
6 Diabetes & Metabolism Journal - Volume 40(3); June 2016 2016-07-12 1,953
5 Diabetes & Metabolism Journal - Volume 40(1); February 2016 2016-07-05 1,953
4 Diabetes & Metabolism Journal - Volume 39(6); December 2015 2016-01-19 1,949
3 Diabetes & Metabolism Journal - Volume 41(3); June 2017 2017-07-11 1,724
2 Diabetes & Metabolism Journal - Volume 40(5); October 2016 2017-01-02 1,596
1 Diabetes & Metabolism Journal - Volume 41(2); April 2017 2017-06-29 1,346

목록

Gets the previous 5 pages.   Go to previous page.  1   2   [3]     Go to next page.  Gets the next  5 pages.